Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chicago Stem Cell Therapy & Pain Management Institute offers outpatient regenerative medicine procedures including stem cell injections, exosome-based therapies, and PRP. They report high patient satisfaction with an average of up to ~80% symptom relief across various chronic pain indications. Treatments focus on tissue repair/regeneration with minimal downtime. All procedures adhere to FDA guidelines using rigorously screened donor material when applicable. Clinical results cited include both published studies in the field and self-reported patient outcomes; no proprietary clinical trial data disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chicago Stem Cell Therapy & Pain Management Institute.